Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Elevated plasma cotinine is associated with an increased risk of developing IBD, especially among users of combusted tobacco
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Clinical chemistry.ORCID iD: 0000-0003-0787-3368
Umeå University, Faculty of Medicine, Department of Pharmacology and Clinical Neuroscience.
Show others and affiliations
2020 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 15, no 7, article id e0235536Article in journal (Refereed) Published
Abstract [en]

Objective: Smoking has previously been associated with inflammatory bowel disease (IBD), but no study has reported on cotinine, an objective, biochemical measure of tobacco use. We aimed at testing the hypothesis that cotinine levels among healthy subjects are associated with an increased risk of developing IBD in later life.

Design: We analysed plasma cotinine and evaluated corresponding lifestyle questionnaires that included tobacco habits in subjects (n = 96) who later developed late-onset IBD (70 ulcerative colitis (UC) and 26 Crohn’s disease (CD)) and in sex and age-matched controls (n = 191).

Results: Patients who later developed IBD had significantly higher plasma cotinine levels compared to controls. In multivariable analysis, higher log-cotinine was associated with a higher risk of developing IBD (OR 1.34 (95% CI 1.01–1.63)). After stratifying for time to diagnosis, the association was only significant in subjects with shorter time (< 5.1 years) to diagnosis (OR 1.45 (1.09–1.92)). The findings were similar for UC- and CD-cases, but did not reach statistical significance in CD-cases. Although plasma cotinine concentrations were higher in snuff users compared to combusted tobacco users, no increase in the risk of IBD and lower risk of developing IBD among subjects with shorter time (< 5.1 years) to diagnosis was seen among snuff users.

Conclusions: Cotinine, a biomarker of tobacco use, is associated with increased risk of developing late-onset IBD in general, and UC in particular. No increased risk among snuff users indicates that other components in combusted tobacco than nicotine may be involved in the pathogenesis of IBD among smokers.

Place, publisher, year, edition, pages
Public Library of Science (PLOS) , 2020. Vol. 15, no 7, article id e0235536
National Category
Gastroenterology and Hepatology
Identifiers
URN: urn:nbn:se:umu:diva-173880DOI: 10.1371/journal.pone.0235536ISI: 000549913100038PubMedID: 32614903Scopus ID: 2-s2.0-85087472900OAI: oai:DiVA.org:umu-173880DiVA, id: diva2:1456754
Funder
Region Västerbotten, VLL-678111Region Västerbotten, VLL-582981Swedish Research Council, VR 2017-00650Available from: 2020-08-06 Created: 2020-08-06 Last updated: 2025-02-11Bibliographically approved
In thesis
1. Lifestyle, biomarkers and the risk of developing inflammatory bowel disease
Open this publication in new window or tab >>Lifestyle, biomarkers and the risk of developing inflammatory bowel disease
2023 (English)Doctoral thesis, comprehensive summary (Other academic)
Alternative title[sv]
Livsstil, biomarkörer och risken att utveckla inflammatorisk tarmsjukdom
Abstract [en]

Introduction: Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic disease causing inflammation in the gut mucosa. The pathogenesis involves alteration in gut microbiota and in the intestinal barrier due to genetic factors, environmental exposure and dysregulation of the immune response. Several environmental risk factors and risk genes have been identified, but still, the pathogenesis is not fully understood. 

Methods: Included papers are all case-control studies based on previously collected data stored with the biobank in Umeå, Sweden. Cases are individuals that participated in the Northern Sweden Health and Disease Study (NSHDS) at least one year before developing IBD. Information was available for all cases regarding age, time and place for inclusion in NSHDS, height and weight, sex and tobacco use. Part of the cases also had available data from a detailed food-frequency questionnaire. For each available case, controls matched for age, sex and time and place were selected. Analysed factors included tobacco use, with smoking and snuff use analysed separately), cotinine (a metabolite of nicotine), iron status (including ferritin, iron, transferrin and transferrin saturation), B-vitamins and tryptophan metabolites. 

Results: Smoking was associated with an increased risk of developing IBD both based on questionnaire data and using cotinine as a marker for exposure. Snuff use was not associated with risk for developing IBD. A lower ferritin was associated with an increased risk of developing IBD, whereas no association was seen for other iron status analytes. When analysing iron deficiency based on ferritin and CRP, it was shown that iron deficiency was more common among men before onset of IBD, whereas no difference was seen for women. Active vitamin B6 was lower among cases compared to controls, as well as an index indicating functional B6 deficiency. Kynurenic acid and xanthurenic acid, both tryptophan metabolites with immunomodulatory properties, were lower among cases than controls. For CD only, picolinic acid was lower among cases later developing IBD.

Discussion: Smoking increases the risk of developing both UC and CD. Snuff use did not increase the risk for IBD, indicating that tobacco exposure is not the reason for increased IBD risk. Low ferritin indicates an early pathological process affecting iron storage unrelated to inflammation. Changes in vitamin B6 and tryptophan metabolites might indicate early pathological processes possibly related to gut microbiota changes. 

To conclude, this dissertation shows that multiple differences between individuals later developing IBD and controls can be seen years before IBD diagnosis. Some of which give insight to early pathophysiology in IBD.

Place, publisher, year, edition, pages
Umeå: Umeå University, 2023. p. 86
Series
Umeå University medical dissertations, ISSN 0346-6612 ; 2247
Keywords
Inflammatory bowel disease, ulcerative colitis, Crohn's disease, smoking, cotinine, iron deficiency, ferritin, pyridoxal-5-phosphate, kynurenine pathway
National Category
Clinical Medicine
Research subject
Clinical Chemistry; Internal Medicine
Identifiers
urn:nbn:se:umu:diva-208115 (URN)978-91-8070-035-1 (ISBN)978-91-8070-034-4 (ISBN)
Public defence
2023-06-02, Betula, Byggnad 6M, Norrlands universitetssjukhus, Umeå, 13:00 (Swedish)
Opponent
Supervisors
Available from: 2023-05-12 Created: 2023-05-09 Last updated: 2023-05-10Bibliographically approved

Open Access in DiVA

fulltext(460 kB)209 downloads
File information
File name FULLTEXT01.pdfFile size 460 kBChecksum SHA-512
7d092ef69e5377cc6c7699319a262a6e84907eaaadf803361e4873a9a0f46096436bfdda1c4cac21b15cfd54b1750e9b8dd7521017542868006f6e06f0464ee1
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Widbom, LovisaSchneede, JørnKarling, PontusHultdin, Johan

Search in DiVA

By author/editor
Widbom, LovisaSchneede, JørnKarling, PontusHultdin, Johan
By organisation
Clinical chemistryDepartment of Pharmacology and Clinical NeuroscienceSection of Medicine
In the same journal
PLOS ONE
Gastroenterology and Hepatology

Search outside of DiVA

GoogleGoogle Scholar
Total: 209 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 369 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf